Rail Study definition

Rail Study means a study in accordance with the Scope of Works.
Rail Study means a Pre-feasibility Study or Feasibility Study, as applicable, in accordance with the Scope of Works.

Examples of Rail Study in a sentence

  • Aurizon Network must carry out, or procure the carrying out of, the Rail Study.

  • As soon as reasonably practicable after the end of each Month, Aurizon Network must give the Study Funder a report (Progress Report) specifying reasonable details of the progress in relation to the carrying out of the Rail Study as at the end of that Month.

  • Regular updates to freight rail planning documents, including the San ▇▇▇▇▇ Bay Ports Rail Study and POLB Rail Primer document continued stakeholder interest and feedback related to the Project.

  • As soon as reasonably practicable after the end of each Month, Aurizon Network must give the Customer a report (Progress Report) specifying reasonable details of the progress in relation to the carrying out of the Rail Study as at the end of that Month.

  • The on-dock capacity increases and utilization was quantified based upon detailed on- dock yard capacity/demand and rail system simulation analyses as described in the San ▇▇▇▇▇ Bay Ports Rail Study Update (see attachments and PSRE), and updated recently for several port container terminal projects.

  • If the Study Funder Committee decides to approve the Scope of Works, then the Scope of Works so submitted by Aurizon Network shall be the Approved Scope of Works for the Rail Study.

  • TxDOT began public comment in 2013 on the Texas-Oklahoma Rail Study that stretches over 850 miles from Oklahoma City to Brownsville.

  • The RFWG discussed the need for the following four possible future freight studies: Regional Freight Rail Study Kenton Rail Line Study Willamette River Channel Deepening Study Regional Freight Delay and Commodities Movement Study The RFWG recommended that the Regional Freight Delay and Commodities Movement Study should be included as a future freight study.

Related to Rail Study

  • Pivotal Study means (a) a Phase 3 Study that is intended by Celgene to be submitted (together with any other registration trials that are prospectively planned when such Phase 3 Study is initiated) for Regulatory Approval in the U.S. or the EU, or (b) any other clinical study that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which clinical study is a registration trial intended to be sufficient for filing an application for a Regulatory Approval for the Licensed Product in the U.S. or another country or some or all of an extra-national territory, solely as evidenced by the acceptance for filing for a Regulatory Approval for such product after completion of such study.

  • Phase I Study means a human clinical trial in any country that would satisfy the requirements of 21 C.F.R. § 312.21(a) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Phase 3 Study means a clinical study of a drug candidate in human patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The relevant drug candidate may be administered to patients as a single agent or in combination with other investigational or marketed agents.